Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Betaseron unit-dose program from HMI to address compliance, dosing issues.

Executive Summary

HMI PHARMACEUTICAL UNIT-DOSE BETASERON PROGRAM enhances ease of dose escalation and dose titration for the multiple sclerosis therapy, the company maintains in promotional materials. As part of its Betaseron "disease management" program for MS patients, HMI is retailing custom unit-dose packages of Betaseron (Chiron/Berlex' recombinant human beta interferon-1b).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027442

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel